Bliss GVS Pharma Limited (BLISSGVS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 24.22B |
| Enterprise Value | 24.09B |
| P/E Ratio | 42.72 |
| PEG Ratio | 0.83 |
| Price/Sales Ratio | 5.93 |
| Price/Book Ratio | 4.73 |
| Enterprise/Revenue | 5.91 |
| Enterprise/EBITDA | 23.32 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 9.27B |
| Revenue/Share | 85.22 |
| Gross Profit | 5.02B |
| EBITDA | 2.35B |
| Net Income | 1.29B |
| Diluted EPS | 12 |
Balance Sheet
| Total Cash | 1.89B |
| Total Cash/Share | 19.82 |
| Total Debt | 217.5M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 4.02 |
| Book Value Per Share | 113.22 |
Price History
| 52-Week Change | 238.34 |
| 52-Week High | 553 |
| 52-Week Low | 118 |
| Moving Average 50 Days | 406.87 |
| Moving Average 200 Days | 243.43 |
Statistics
| Average Volume | 2.11M |
| Shares Outstanding | 106.06M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.5 |
| Trailing Annual Dividend Yield | 0.29 |
| Payout Ratio | 0.04 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
